Wells Fargo’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-30,941
Closed -$731K 7194
2023
Q4
$731K Buy
30,941
+10,319
+50% +$244K ﹤0.01% 3296
2023
Q3
$307K Sell
20,622
-20,259
-50% -$302K ﹤0.01% 3788
2023
Q2
$448K Buy
40,881
+40,262
+6,504% +$441K ﹤0.01% 3817
2023
Q1
$5.4K Buy
619
+82
+15% +$715 ﹤0.01% 5710
2022
Q4
$3.37K Sell
537
-162
-23% -$1.02K ﹤0.01% 5553
2022
Q3
$3K Sell
699
-10
-1% -$43 ﹤0.01% 5774
2022
Q2
$3K Sell
709
-9,150
-93% -$38.7K ﹤0.01% 5955
2022
Q1
$31K Sell
9,859
-21,122
-68% -$66.4K ﹤0.01% 5523
2021
Q4
$105K Buy
30,981
+26,784
+638% +$90.8K ﹤0.01% 5206
2021
Q3
$16K Sell
4,197
-40,127
-91% -$153K ﹤0.01% 5730
2021
Q2
$194K Sell
44,324
-180,618
-80% -$791K ﹤0.01% 4748
2021
Q1
$1.02M Buy
224,942
+44,161
+24% +$200K ﹤0.01% 3974
2020
Q4
$1.04M Buy
180,781
+129,758
+254% +$744K ﹤0.01% 3935
2020
Q3
$369K Sell
51,023
-13,067
-20% -$94.5K ﹤0.01% 4444
2020
Q2
$224K Buy
64,090
+18,782
+41% +$65.6K ﹤0.01% 4681
2020
Q1
$67K Sell
45,308
-3,089
-6% -$4.57K ﹤0.01% 5033
2019
Q4
$95K Sell
48,397
-38,656
-44% -$75.9K ﹤0.01% 5108
2019
Q3
$446K Buy
87,053
+16,595
+24% +$85K ﹤0.01% 4338
2019
Q2
$504K Sell
70,458
-69,477
-50% -$497K ﹤0.01% 4263
2019
Q1
$1.86M Sell
139,935
-1,921
-1% -$25.5K ﹤0.01% 3393
2018
Q4
$1.12M Buy
141,856
+4,063
+3% +$32K ﹤0.01% 3686
2018
Q3
$1.53M Buy
137,793
+45,929
+50% +$509K ﹤0.01% 3583
2018
Q2
$1.23M Buy
91,864
+39,141
+74% +$525K ﹤0.01% 3786
2018
Q1
$685K Buy
52,723
+13,577
+35% +$176K ﹤0.01% 4103
2017
Q4
$360K Buy
39,146
+38,646
+7,729% +$355K ﹤0.01% 4501
2017
Q3
$4K Buy
+500
New +$4K ﹤0.01% 5682